down arrow

Vivo Bio Tech

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE380K01017
  • NSEID:
  • BSEID: 511509
INR
34.55
-0.34 (-0.97%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 2.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Vivo Bio Tech
Guj. Terce Labs.
Roopa Industries
Mankind Pharma
Vista Pharma.
Medi Caps
Shelter Pharma
Why is Vivo Bio Tech Ltd. ?
1
Weak Long Term Fundamental Strength with a -3.37% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.97
  • The company has been able to generate a Return on Equity (avg) of 7.95% signifying low profitability per unit of shareholders funds
2
Stock is technically in a Mildly Bearish range
  • The technical trend has deteriorated from Sideways on 25-Mar-25 and has generated -5.43% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
Below par performance in long term as well as near term
  • Along with generating -22.11% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vivo Bio Tech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Vivo Bio Tech
-23.09%
-0.46
47.75%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-3.37%
EBIT Growth (5y)
6.44%
EBIT to Interest (avg)
1.97
Debt to EBITDA (avg)
2.63
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
22.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.64%
ROE (avg)
7.95%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
8
Industry P/E
33
Price to Book Value
0.98
EV to EBIT
9.89
EV to EBITDA
5.53
EV to Capital Employed
0.99
EV to Sales
2.50
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
10.73%
ROE (Latest)
12.47%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
ROCE(HY)

Highest at 14.57 %

PAT(9M)

Higher at Rs 6.22 Cr

DEBT-EQUITY RATIO(HY)

Lowest at 0.97 times

-4What is not working for the Company
PAT(Q)

At Rs 0.82 cr has Fallen at -56.0 %

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 1.37 cr

Loading Valuation Snapshot...
Here's what is working for Vivo Bio Tech
Debt-Equity Ratio - Half Yearly
Lowest at 0.97 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Vivo Bio Tech
Profit After Tax (PAT) - Quarterly
At Rs 0.82 cr has Fallen at -56.0 %
over average PAT of the previous four quarters of Rs 1.87 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.37 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents